Overall and event-free survival are not important by the use of myeloablative therapy following multiple myeloma: a prospective randomised phase 3 study

C.M. Segeren; P. Sonneveld; B. van der Holt; A.J. Croockewit; G.E.G. Verhoef; J.J. Cornelissen; M.R. Schaafsma; M.H.J. van Oers; P.W. Wijermans; W.E. Fibbe; S. Wittebol; H.C. Schouten; M. van Marwijk Kooy; D.H. Biesma; J.W. Baars; R. Slater; M.C.M. Steijaert; I. Buijt; H.M. Lokhorst

Overall and event-free survival are not important by the use of myeloablative therapy following multiple myeloma: a prospective randomised phase 3 study

Translated title of the contribution: Overall and event-free survival are not important by the use of myeloablative therapy following multiple myeloma: a prospective randomised phase 3 study

C.M. Segeren
, P. Sonneveld
, B. van der Holt
, A.J. Croockewit
, G.E.G. Verhoef
, J.J. Cornelissen
, M.R. Schaafsma
, M.H.J. van Oers
, P.W. Wijermans
, W.E. Fibbe
, S. Wittebol
, H.C. Schouten
, M. van Marwijk Kooy
, D.H. Biesma
, J.W. Baars
, R. Slater
, M.C.M. Steijaert
, I. Buijt
, H.M. Lokhorst

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Overall and event-free survival are not important by the use of myeloablative therapy following multiple myeloma: a prospective randomised phase 3 study
Original language	Undefined/Unknown
Pages (from-to)	2144-2151
Number of pages	8
Journal	Blood
Volume	101
Publication status	Published - 2003

Cite this

Segeren, C. M., Sonneveld, P., van der Holt, B., Croockewit, A. J., Verhoef, G. E. G., Cornelissen, J. J., Schaafsma, M. R., van Oers, M. H. J., Wijermans, P. W., Fibbe, W. E., Wittebol, S., Schouten, H. C., van Marwijk Kooy, M., Biesma, D. H., Baars, J. W., Slater, R., Steijaert, M. C. M., Buijt, I., & Lokhorst, H. M. (2003). Overall and event-free survival are not important by the use of myeloablative therapy following multiple myeloma: a prospective randomised phase 3 study. Blood, 101, 2144-2151.

@article{5d4a58b066d347fc93d59f4e60e88536,

title = "Overall and event-free survival are not important by the use of myeloablative therapy following multiple myeloma: a prospective randomised phase 3 study",

author = "C.M. Segeren and P. Sonneveld and \{van der Holt\}, B. and A.J. Croockewit and G.E.G. Verhoef and J.J. Cornelissen and M.R. Schaafsma and \{van Oers\}, M.H.J. and P.W. Wijermans and W.E. Fibbe and S. Wittebol and H.C. Schouten and \{van Marwijk Kooy\}, M. and D.H. Biesma and J.W. Baars and R. Slater and M.C.M. Steijaert and I. Buijt and H.M. Lokhorst",

year = "2003",

language = "Undefined/Unknown",

volume = "101",

pages = "2144--2151",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

}

Segeren, CM, Sonneveld, P, van der Holt, B, Croockewit, AJ, Verhoef, GEG, Cornelissen, JJ, Schaafsma, MR, van Oers, MHJ, Wijermans, PW, Fibbe, WE, Wittebol, S, Schouten, HC, van Marwijk Kooy, M, Biesma, DH, Baars, JW, Slater, R, Steijaert, MCM, Buijt, I & Lokhorst, HM 2003, 'Overall and event-free survival are not important by the use of myeloablative therapy following multiple myeloma: a prospective randomised phase 3 study', Blood, vol. 101, pp. 2144-2151.

TY - JOUR

T1 - Overall and event-free survival are not important by the use of myeloablative therapy following multiple myeloma: a prospective randomised phase 3 study

AU - Segeren, C.M.

AU - Sonneveld, P.

AU - van der Holt, B.

AU - Croockewit, A.J.

AU - Verhoef, G.E.G.

AU - Cornelissen, J.J.

AU - Schaafsma, M.R.

AU - van Oers, M.H.J.

AU - Wijermans, P.W.

AU - Fibbe, W.E.

AU - Wittebol, S.

AU - Schouten, H.C.

AU - van Marwijk Kooy, M.

AU - Biesma, D.H.

AU - Baars, J.W.

AU - Slater, R.

AU - Steijaert, M.C.M.

AU - Buijt, I.

AU - Lokhorst, H.M.

PY - 2003

Y1 - 2003

M3 - Article

SN - 0006-4971

VL - 101

SP - 2144

EP - 2151

JO - Blood

JF - Blood

ER -